Radioactive hope: first human test for tough prostate cancer
Disease control
Recruiting now
This is the first-ever study in people to test a new radioactive drug called [225Ac]Ac-FL-020 for men with advanced prostate cancer that has spread and no longer responds to standard hormone therapy. The main goals are to find a safe dose and see how the body handles the drug. Re…
Phase: PHASE1 • Sponsor: Full-Life Technologies GmbH • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC